Press Releases

 Filter by Provider

LIBERTY LAKE, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today that it will release financial results for the quarter ended Mar. 31, 2026 at 8:30 a.m. EDT on Tuesday, Apr. 28, 2026. Itron management will host a conference call at 10:00 a.m. EDT to discuss the results.

SAN JOSE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its Board of Directors has authorized an increase of $750 million of common stock to the company’s existing share repurchase program. Including approximately $29 million currently remaining under the prior authorization, the total repurchase authorization stands at approximately $779 million.

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF) announced today the following investor events:

MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery centers (ASC), and hospitals across the United States.

New Leadership Advances Coffman's Long-Term Vision

Cepheus-1-108Q validates Rigetti’s proprietary chiplet-based scaling architecture and is now generally available to Rigetti’s customers and partners via the Rigetti Quantum Cloud Services platform and through Amazon Braket, the quantum computing service by AWS.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its first quarter 2026 earnings before the market opens on Thursday, April 23, 2026.

LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2026 financial results on Friday, May 1, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.

SAN CARLOS, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2026 at 2:15 p.m. ET / 11:15 a.m. PT.

GREENWICH, Conn., April 07, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) will hold its first quarter conference call and webcast on Thursday, April 30, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on www.xpo.com.Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at: www.xpo.com/investorsA replay of the conference call will be available until May 30, 2026, by calling toll-free (from US/Canada) 1-877-660-6853; international callers dial +1-201-612-7415. Use the passcode 13759585. Additionally, the call will be archived on www.xpo.com/investors.About XPOXPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company’s customer-focused organization efficiently moves 16 billion pounds of freight per year, enabled by its proprietary technology. XPO serves 55,000 customers with 592 locations and 37,000 employees in North America and Europe, and is headquartered in Greenwich, Conn., USA. Visit xpo.com for more information, and connect with XPO on LinkedIn, Facebook, X, Instagram and YouTube.Investor ContactBrian Scasserra+1-617-607-6429brian.scasserra@xpo.comMedia ContactCole Horton+1-203-609-6004cole.horton@xpo.com

MEXICO CITY - Apr 7, 2026 - Pilo Tech Co. Inc. (operating under the brand Pilo, part of Dreame Technology’s global smart ecosystem) made its debut at the Dreame Mexico Product Launch, strengthening its market presence in the pet technology sector. As a key component of Dreame Technology’s smart ecosystem, Pilo leverages Dreame’s mature core intelligent algorithm capabilities to apply advanced technological solutions to pet care scenarios, redefining the smart living experience for modern pet-owning households.

The Listicle Citation Advantage is a measurable, structural bias in how AI-powered search engines select and surface third-party sources: pages formatted as ranked lists receive disproportionately more citations than conventional blog posts, tutorials, or longform guides. This pattern, first identified and quantified through seven consecutive days of cross-engine monitoring, suggests that the retrieval-augmented generation pipelines behind modern AI search treat structured listicle content as a lower-cost extraction target, leading to systematic over-representation in AI-generated answers.

Clear, real-time ear insights at home with the MOBI Smart Otoscope for Ears, Nose & Throat Camera, designed for everyday family care

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced the appointment of Clare Kahn, Ph.D., to its Board of Directors.

Arcadia Capital announced today the appointment of Zach Hitchcock as a Managing Director. Zach will lead the firm’s coverage efforts in New York City, focusing on expanding Arcadia’s global tech and tech services expertise and building on its existing advisory capabilities across the ecosystem.

BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its first quarter 2026 financial results on Friday, May 1, 2026, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.

Merrillville, IN - April 07, 2026 - Strategic Automation Group, a marketing and operations firm based in Merrillville, Indiana, is working with businesses to address a common but often overlooked issue: lost revenue caused by slow response times, inconsistent follow-up, and inefficient internal processes. Instead of offering standalone software or generic AI tools, the company focuses on improving how businesses handle leads and manage workflows.

CEO Deven Soni to Present Company Strategy, Operational Update and Q&A on April 10, 2026

Sigma Audio Networks, powered by MediaCo Holding Inc. (Nasdaq: MDIA), today announced a significant expansion of its national audio platform, adding two leading multicultural franchises: Don Cheto and HOT 97 Mornings with Mero.

Newell Brands Inc. (NASDAQ: NWL) today announced its first quarter 2026 earnings results will be released Friday, May 1, 2026 prior to market open and will be followed by a live webcast at 7:30 a.m. ET. To listen to the webcast, please select Events & Presentations from the Investors tab of the Newell Brands website at www.newellbrands.com. The live webcast will be recorded and made available for replay.

Expedition:Earth, a Texas-based multi-brand operator in high-end personalized experiential travel, announced a strategic investment in Iconic Adventures. Iconic is a Steamboat Springs, CO-based tour operator specializing in ultra-high-end bespoke travel experiences for corporate clients, non-profit organizations, universities, family offices, and FIT clients across five continents. This transaction represents Expedition:Earth's second platform partnership and further advances its buy-and-build strategy to establish a leading provider in the sector.

On February 5, 2026, Evercore ISI slashed its price target on Gemini Space Station, Inc. (NASDAQ: GEMI) by 50%, from $15.00 to $10.00, and downgraded the stock from outperform to in line. Within two weeks, Truist Securities cut its target 46%, Needham & Co. cut 57%, and Rosenblatt cut 55%. Find out if you qualify to recover losses from GEMI's decline. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in New Era Energy & Digital, Inc. (NASDAQ: NUAI) during the period from November 6, 2024 through December 29, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or call (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Lufax Holding Ltd (NYSE: LU) of a pending securities class action naming two senior officers as individual defendants. Class Period: April 7, 2023 through January 26, 2025. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Institutional investors holding positions in Hercules Capital, Inc. (NYSE: HTGC) during the period from May 1, 2025 through February 27, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Concorde International Group, Ltd. (NASDAQ: CIGL) during the Class Period of April 21, 2025, through July 14, 2025, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

"We firmly believe that we have accomplished this patient selection goal." That was the promise. The reality: a Phase 3 trial that failed its primary endpoint, and shareholders who lost over 80% of their investment in a single trading session.

Levi & Korsinsky, LLP alerts investors in Pinterest, Inc. (NYSE: PINS) of a pending securities class action naming CEO William Ready and CFO Julia Brau Donnelly as individual defendants under Section 20(a) of the Securities Exchange Act of 1934.

Levi & Korsinsky, LLP alerts investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of a pending securities class action. Class Period: March 26, 2025 through November 4, 2025. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Institutional investors holding positions in ImmunityBio, Inc. (NASDAQ: IBRX) during the period January 19, 2026 through March 24, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Shares lost $1.98 per share, a 21% decline, after an FDA Warning Letter exposed allegedly false promotional claims about the Company's lead drug, ANKTIVA. Request an institutional investor loss assessment or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Jeremy J. Heaton, former Chief Financial Officer of Alight, Inc. (NYSE: ALIT), is named as an individual defendant in a securities class action filed in the United States District Court for the Northern District of Illinois. The action covers purchases between November 12, 2024 and February 18, 2026. Find out if you are entitled to recover investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

From a Class Period high of $85.75 on March 2, 2026, Power Solutions International, Inc. (NASDAQ: PSIX) shares collapsed to $60.91, a decline of $24.84 per share, or nearly 29%, in a single trading session on unusually heavy volume. Levi & Korsinsky, LLP notifies investors who purchased PSIX securities between May 8, 2025 and March 2, 2026 that a securities class action has been filed. Find out if you qualify to recover your per-share losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

The artificial intelligence server market attracted tens of billions in capital as investors poured into companies powering next-generation AI infrastructure. Super Micro Computer, Inc. (NASDAQ: SMCI) rode this wave to nearly $15 billion in fiscal 2024 revenue and $22 billion in fiscal 2025, but a federal indictment now alleges approximately $2.5 billion of those sales were illegal. Levi & Korsinsky, LLP notifies investors in Super Micro Computer, Inc. (NASDAQ: SMCI) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between April 30, 2024 and March 19, 2026. Find out if you qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Heritage Global Inc. (NASDAQ: HGBL) (“Heritage Global,” “HG” or “the Company”), an asset services company specializing in financial and industrial asset transactions, today announced that the Company will release its first quarter 2026 financial results after the market closes on Thursday, May 7, 2026.

"At least $775 million." That was Vital Farms' final revenue promise to shareholders for fiscal year 2025. The actual result: $759.4 million, a shortfall of more than $15.5 million. Levi & Korsinsky, LLP notifies investors in Vital Farms, Inc. (NASDAQ: VITL) that a securities class action has been filed on behalf of purchasers who acquired shares between May 8, 2025 and February 26, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Coty Inc. (NYSE: COTY) during the period November 5, 2025 through February 4, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. (“AMC” or the “Company”) (NYSE: AMC; APE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Brian Properties, Inc. has assumed property management responsibilities for a Class B office/flex property located at 704–708 Deerpath Drive in Vernon Hills, Illinois. The engagement follows the recent acquisition of the asset by an out-of-state investor entering the Chicagoland market.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

LANSING, MI - As longtime religious communities in the United States dwindle and new ones begin to form, a fundamental question continues to surface: How does a group discern whether its inspiration is authentic — and what does the Catholic Church require to make it official?

CLEARWATER, FL - April 7, 2026 - My Injection Training, a Clearwater-based professional education provider for healthcare practitioners, has announced the availability of its comprehensive orthobiologics protocol training program designed specifically for providers seeking to enter or expand within the regenerative medicine space. The new intensive training program equips licensed clinicians with the clinical protocols, demonstration techniques, and practice-building skills needed to confidently offer orthobiologics services and build a sustainable cash-pay biologics program.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. (“PomDoctor” or the “Company”) (NASDAQ: POM).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ODDITY Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Inovio securities between October 10, 2023 and December 26, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv- 01951, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nektar securities between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02261, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Gemini Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”); and/or Gemini securities between September 12, 2025 and February 17, 2026, both dates inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 11 and 15 of the Securities Act of 1933 (the “Securities Act”) and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. (“Regenxbio” or the “Company”) (NASDAQ: RGNX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.